Intervet/Schering-Plough opens vaccine manufacturing facility

Intervet/Schering-Plough Animal Health announces that it opened a state-of-the-art production centre for veterinary vaccines against bacterial infections.

The new facility is located at Biosciences Center Boxmeer, the Netherlands, one of the world's largest veterinary R&D and manufacturing facilities and a cornerstone of the company's global vaccine R&D and production network.

Intervet/Schering-Plough Animal Health, one of the world's largest animal health companies, is investing US$ 22 million in the new building, which has increased the floor space of the bacterial vaccine production unit by more than three-fold from approximately 1,500 to over 5,500 square metre.

It will have four hi-tech production lines for bacterial vaccines with a media preparation capacity in fermentors ranging from 200 to 1,500 litres.

The availability of state-of-the-art fermentors and clean rooms, in combination with efficient, integrated up-/downstream processing operations and automation makes the new unit a landmark in veterinary bacterial vaccine manufacturing.